1. Home
  2. PGEN vs GLP Comparison

PGEN vs GLP Comparison

Compare PGEN & GLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$5.42

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Global Partners LP

GLP

Global Partners LP

HOLD

Current Price

$48.22

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
GLP
Founded
1998
2005
Country
United States
United States
Employees
N/A
4700
Industry
Biotechnology: Pharmaceutical Preparations
Oil Refining/Marketing
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
PGEN
GLP
Price
$5.42
$48.22
Analyst Decision
Buy
Hold
Analyst Count
5
1
Target Price
$8.33
$46.00
AVG Volume (30 Days)
4.0M
64.5K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
6.40%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
$64.13
Revenue Next Year
$81.04
$11.74
P/E Ratio
N/A
$23.28
Revenue Growth
N/A
N/A
52 Week Low
$1.57
$39.58
52 Week High
$6.04
$53.25

Technical Indicators

Market Signals
Indicator
PGEN
GLP
Relative Strength Index (RSI) 58.35 55.34
Support Level $3.96 $46.01
Resistance Level $6.04 $50.58
Average True Range (ATR) 0.28 1.28
MACD -0.01 0.06
Stochastic Oscillator 82.95 81.29

Price Performance

Historical Comparison
PGEN
GLP

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.

Share on Social Networks: